Miscellaneous20-Jun-2025 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Receives FDA ...

SENTI-202, a groundbreaking CAR NK-cell therapy, targets relapsed/refractory AML, offering hope for patients with limited ...

The financing round was jointly led by new investor Regeneron Ventures and current investor Deerfield Management.

The Buss family is selling the Los Angeles Lakers after nearly 50 years of ownership in a record-breaking $10 billion deal to Dodgers owner Mark Walter. NBA legend Magic Johnson, a part-owner of the ...

The trial aims to assess the safety, pharmacodynamics, efficacy, and pharmacokinetics of the therapy in nearly 255 subjects.